...
首页> 外文期刊>BMC Infectious Diseases >Shiga toxin-producing escherichia coli infections in Norway, 1992–2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome
【24h】

Shiga toxin-producing escherichia coli infections in Norway, 1992–2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome

机译:挪威,1992-2012年,产生志贺毒素的大肠埃希菌感染:分离株的表征和溶血性尿毒症综合征的危险因素的识别

获取原文

摘要

Shiga toxin-producing E. coli (STEC) infection is associated with haemolytic uremic syndrome (HUS). Therefore Norway has implemented strict guidelines for prevention and control of STEC infection. However, only a subgroup of STEC leads to HUS. Thus, identification of determinants differentiating high risk STEC (HUS STEC) from low risk STEC (non-HUS STEC) is needed to enable implementation of graded infectious disease response. A national study of 333 STEC infections in Norway, including one STEC from each patient or outbreak over two decades (1992–2012), was conducted. Serotype, virulence profile, and genotype of each STEC were determined by phenotypic or PCR based methods. The association between microbiological properties and demographic and clinical data was assessed by univariable analyses and multiple logistic regression models. From 1992 through 2012, an increased number of STEC cases including more domestically acquired infections were notified in Norway. O157 was the most frequent serogroup (33.6?%), although a decrease of this serogroup was seen over the last decade. All 25 HUS patients yielded STEC with stx2, eae, and ehxA. In a multiple logistic regression model, age ≤5?years (OR?=?16.7) and stx2a (OR?=?30.1) were independently related to increased risk of HUS. eae and hospitalization could not be modelled since all HUS patients showed these traits. The combination of low age (≤5?years) and the presence of stx2a, and eae gave a positive predictive value (PPV) for HUS of 67.5?% and a negative predictive value (NPV) of 99.0?%. SF O157:[H7] and O145:H?, although associated with HUS in the univariable analyses, were not independent risk factors. stx1 (OR?=?0.1) was the sole factor independently associated with a reduced risk of HUS (NPV: 79.7?%); stx2c was not so. Our results indicate that virulence gene profile and patients’ age are the major determinants of HUS development.
机译:产生志贺毒素的大肠杆菌(STEC)感染与溶血性尿毒症综合征(HUS)相关。因此,挪威实施了预防和控制STEC感染的严格指南。但是,只有STEC的一个子组会导致HUS。因此,需要确定区分高危STEC(HUS STEC)和低危STEC(non-HUS STEC)的决定因素,以实现分级的传染病反应。挪威对333例STEC感染进行了一项全国性研究,其中包括在过去的20年中(1992-2012年)每位患者或一次暴发的一名STEC。通过基于表型或PCR的方法确定每个STEC的血清型,毒力概况和基因型。通过单变量分析和多元逻辑回归模型评估了微生物学特性与人口统计学和临床​​数据之间的关联。从1992年到2012年,挪威通报了更多的STEC病例,包括更多的家庭获得性感染。 O157是最常见的血清群(33.6%),尽管在过去十年中该血清群减少了。所有25例HUS患者均产生带有stx2,eae和ehxA的STEC。在多元logistic回归模型中,年龄≤5岁(OR?=?16.7)和stx2a(OR?=?30.1)与HUS风险增加独立相关。由于所有HUS患者均表现出这些特征,因此无法对eae和住院进行建模。低年龄(≤5岁)和stx2a的存在以及eae的结合,对HUS的阳性预测值(PPV)为67.5%,阴性预测值(NPV)为99.0%。 SF O157:[H7]和O145:H?尽管在单变量分析中与HUS相关,但不是独立的危险因素。 stx1(OR == 0.1)是与降低HUS风险独立相关的唯一因素(NPV:79.7%)。 stx2c并非如此。我们的结果表明,毒力基因概况和患者年龄是HUS发展的主要决定因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号